Andere talen Bio-Rad Laboratories, Inc.

Aandelen

BIO

US0905722072

Beurs gesloten - Nyse Andere beurzen 22:00:02 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
279,7 ^USD	-0,46%		-6,90%	-13,37%

15/04	BIO-RAD LABORATORIES, INC. : Zacks Investment Research handhaaft koopadvies	ZM
11/04	Oncocyte Corporation en Bio-Rad Laboratories, Inc. Partners voor wereldwijde lancering van transplantatietest	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18/04
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15/04
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11/04
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11/04
Bio-Rad Laboratories COO Andrew Last to Retire in September	10/04
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10/04
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10/04
North American Morning Briefing : Focus Turns to -2-	04/04
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25/03
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20/03
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as Chief Financial Officer, Effective April 15, 2024	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20/03
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29/02
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day	22/02
Bio Rad Labs rises after posting upbeat fourth-quarter profit	16/02
Bio-Rad: Q4 Earnings Snapshot	15/02
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	15/02
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Posts Q4 Revenue $681.2M, vs. Street Est of $686.6M	15/02
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Reports Q4 EPS $3.10, vs. Street Est of $2.87	15/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bio-Rad Laboratories, Inc.

Aandelen

BIO

US0905722072

Andere talen

Filters